Introduction: Lp(a), a new lipid frontier in CV risk management & target for therapy
This presentation by prof. Stroes was part of the EBAC-accredited symposium "Lp(a), a new lipid frontier in CV risk management and target for therapy" held during the virtual ESC Congress 2020.
Prof. Erik Stroes, MD - Professor of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
his recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from